2018 Indexes Report Card
MarketGrader Health Care Index
Top Large Caps (Top 3 of 27)
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Incorporated | 85.3 | $47,536.10 | US |
| BIIB | Biogen Inc. | 82.4 | $42,732.70 | US |
| EXEL | Exelixis, Inc. | 80.0 | $6,579.12 | US |
Top Mid Caps (Top 3 of 8)
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| CORT | Corcept Therapeutics Incorporated. | 80.3 | $1,476.82 | US |
| SUPN | Supernus Pharmaceuticals, Inc. | 74.8 | $1,421.89 | US |
| ARNA | Arena Pharmaceuticals, Inc. | 73.5 | $2,776.25 | US |
Top Small Caps (Top 3 of 5)
| Symbol | Name | Overall Grade | Market Cap | Country |
|---|---|---|---|---|
| BSTC | BioSpecifics Technologies Corp. | 79.2 | $430.49 | US |
| EGRX | Eagle Pharmaceuticals, Inc. | 77.6 | $862.89 | US |
| ANIK | Anika Therapeutics, Inc. | 59.3 | $774.74 | US |
Companies with Most Selections Among Current Components
| Symbol | Name | Grade | times | Country |
|---|---|---|---|---|
| AMGN | Amgen Inc. | 66.3 | 46 Times | US |
| BIIB | Biogen Inc. | 82.4 | 42 Times | US |
| ISRG | Intuitive Surgical, Inc. | 65.8 | 40 Times | US |
| RMD | ResMed Inc. | 58.5 | 33 Times | US |
| CELG | Celgene Corporation | 77.6 | 31 Times | US |
| SYK | Stryker Corporation | 67.7 | 27 Times | US |
| ALGN | Align Technology, Inc. | 75.0 | 26 Times | US |
| ALXN | Alexion Pharmaceuticals, Inc. | 71.3 | 24 Times | US |
| ILMN | Illumina, Inc. | 65.6 | 24 Times | US |
| AMED | Amedisys, Inc. | 65.4 | 22 Times | US |
Index Bio
| Average Market Cap | $28,248.61 |
| Median Market Cap | $6,845.51 |
| Average 3 Mo. Dollar Volume | $158,725,729.50 |
| Average 3 Mo. Trading Volume | 1,512,959 |
| Last Rebalance Date | 05/20/2019 |
| Companies Replaced | 14 |
| Biggest Sector Increase | Health Care |
| Biggest Sector Decrease | Health Care |
| Companies Overlapping S&P 500 | 20 |
Fundamental Attributes
| Trailing P/E Ratio (12 Mo.) | 23.35 |
| Forward P/E Ratio (12 Mo.) | 24.11 |
| Price/Book Ratio | 6.55 |
| Avg. Revenue Chg. - 3 Yr | 47.12% |
| Avg. Op. Income Chg. - 3 Yr. | 112.87% |
| Avg. EPS Growth - 3 Yr. | 29.36% |
| Avg. EPS Growth - 1 Yr. | 20.07% |
| Avg. Operating Margin | 24.88% |
| Avg. LT Debt to Total Capital | 19.4% |
| Avg. Return on Equity | 24.37% |
| Dividend Yield | 0.0% |
Index Average Grade
| MarketGrader Health Care Index Index | 66.2 |
Country Allocation
For more information on this index please contact us